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Acute aortic dissection frequently causes life-threatening organ ischemia. The optimal therapy for acute type-B aortic
dissection is still controversial. Surgery for acute dissection with organ malperfusion is known to carry a high
morbidity and mortality; however endovascular treatment is becoming an alternative form of treatment. We report a
clinical case of emergency percutaneous thoracal aorta endovascular stenting and renal artery stenting in a patient who
had renal malperfusion and acute renal failure due to acute type-B dissection. The present case is a fundamental
examples of collaboration between the cardiologist and cardiovascular surgeon in a hybrid procedure.
 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
Keywords: Aortic dissection, Endovascular stenting, Renal stentingAcute aortic dissection (AD) is a life-threaten-ing clinical entity that may cause organ
ischemia during the acute stage. Approximately
30% of patients with AD develop organ malperfu-
sion increasing surgical mortality and morbidity
ranging from 50% to 80% [1]. We report a case of
percutaneous thoracic aorta endovascular stenting
and renal artery stenting in a patient who had re-
nal malperfusion due to acute Stanford type-B
dissection.
Case
A 59-year-old man was admitted to our hospital
with back pain. His blood pressure was 220–90/1016–7315  2012 King Saud University.
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doi:10.1016/j.jsha.2012.02.002mmHg and his pulse rate was 78 beats/min. He
had chronic hypertension, dyslipidemia and a his-
tory of heavy smoking. Physical examination
showed no signs of visceral ischemia. ECG and
chest roentgenogram were normal. Peripheral
arterial pulses were well palpable in the upper
and lower extremities. Laboratory data were unre-
markable except for increase in white blood cell
count. Contrast enhanced CT revealed an acute
aortic dissection extending from the descending
aorta to the right and the left common iliac arteries
(Fig. 1). Intimal tear located within the aorta just
distal to the origin of the left subclavian artery
made certain diagnosis of Stanford type-B dissec-
tion. Initially we did not observe any end organ
Figure 1. Type B acute aortic dissection lies through to the left renal artery.
Figure 2. Endovascular graft closing the proximal aortic tear flap and aortic false lumen.
Figure 3. Renal artery occlusion by dissection and successfully implanted stent in left renal artery.
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Figure 4. Third month CT aortography shows aortic graft stent and left kidney stents.
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with medical therapy. Approximately 20 h later,
his BUN and creatinine levels (6.2 mg/dl) began
to increase and he was taken to the catheter room
where he received an improved thoracic aorta
endovascular graft stent and renal artery stent
replacement in the same setting. We first placed
a 36 mm  15 cm range Valiant Captiva graft into
the descending aorta (Fig. 2). Afterward, on con-
trol aortography we observed a totally occluded
left renal artery with extending false lumen and
we placed two bare metal stents (4.5  18 mm)
into the left renal artery (Fig. 3). Procedure was
completed successfully without any complica-
tions. During the hospital stay, the patient’s creat-
inine levels decreased and normalized. We
discharged the patient uneventfully after eight
days. After three months, CT aortography re-
vealed stable and open aortic and renal stents
with an almost closed false lumen (Fig. 4).Discussion
Although the etiology of AD remains unclear
predisposing factors have been defined. The most
important predisposing factor for AD is hyperten-
sion coexisting in the range of 70–90% and more
common in distal than in proximal dissections.
Other predisposing factors are congenital disor-
ders of the connective tissue, in particular Marfan
syndrome and to a lesser extend Ehler–Danlos
syndrome [2]. Dissections are predominate in
male patients by a ratio of 3:1 [3].In this case, the left renal artery was totally oc-
cluded and right kidney was subjected to severe
malperfusion due to a large aortic false lumen
which is the possible mechanism of acute renal
failure and the creatinine rise.
The optimal therapy for acute type-B aortic dis-
section with visceral organ ischemia remains con-
troversial [4]. There is a consensus that medical
treatment is better than surgery for uncompli-
cated type-B dissection [4]. Emergency surgical
intervention with replacement of the descending
aorta is the only effective therapeutic option for
patients with life threatening complications, such
as rupture and impending rupture with rapid in-
crease of aortic diameter and refractory pain [1].
Different surgical techniques have been success-
fully used, such as the adventitial inversion tech-
nique which obliterates the false lumen and
converts a dissected aorta into a conduit with
tough adventitia on the inside and outside [5],
the proximal local aortic prosthetic approach [6],
femoral–femoral bypass, axillo-femoral bypass or
surgical fenestration [7]. Another option is making
fenestration via retroperitoneal approach; how-
ever in our clinic we prefer percutaneous ap-
proach without surgery if rapid organization is
possible. We routinely perform endovascular
intervention for type B dissection when there is
proper anatomy. Despite improving surgical tech-
niques and accumulated experience, open surgi-
cal repair is still accompanied by high mortality;
the mortality rate is up to 27% in elective proce-
dures and over 50% under emergency conditions
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cardiopulmonary bypass in acute phase is accom-
panied by high risk. As for such cases with visceral
or lower extremity ischemia, mortality and mor-
bidity will increase due to ischemia-reperfusion
injury for malperfused organs and the systemic ef-
fects of metabolites [9]. The advent of endovascu-
lar prostheses to treat descending thoracic aortic
lesions offered an alternate approach in patients
with dissections and severe co-morbidities who
were poor candidates for open surgery. The po-
tential benefits of endovascular surgery for dissec-
tions include low access trauma, minimal loss of
blood, no need for aortic cross clamping, early
recovery from perioperative stress, shorter inten-
sive care unit and hospital stays, decreased mor-
bidity and mortality and finally, cost-effectiveness.
During the endovascular approach of type B dis-
section, one of the possible complications is the
extension of the dissection retrogradely to the
proximal segment. In this case we did not observe
this dissection complication but operators must be
cautious in this regard.
Treatment of AD by endovascular grafting car-
ries some risks. The most serious is rupture of
the aorta and the another is leakage which can oc-
cur in 25% of patients. Also we have observed
thromboembolism in 8% of patients. All these
complications are more commonly observed in
the emergent cases of acute dissections rather
than chronic ones [4]. On admission to the emer-
gency room, our case had only back pain without
end organ damage or rupture. We decided to fol-
low up with medical treatment in the intensive
care unit. After 20 h his creatinine and BUN levels
began to increase and he was taken to the angiog-
raphy theatre where we placed an endovascular
stent in the descending aorta where we found
the dissection entry. We then we performed renal
angiography and observed that the left renal ar-
tery was occluded by intimal flap. We placed two
stents in left renal artery and then left kidney
was very well perfused. Upon follow-up the pa-
tient’s creatinine and BUN levels gradually de-
creased and became normal by the third day.
We discharged him without pain or end organ
damage.Conclusion
As a result we think that as an alternative
approach to surgery, endovascular stenting andother hybrid interventions should be performed
as soon as possible in Stanford type B dissections
and acute renal failure as safe. Acute renal failure
induced by acute aortic dissection and occluded
renal artery might be treated safely with stent
implantation in the same setting of the endovas-
cular aortic graft procedure, but we need more
experience and more patients to observe long
term results. In recent times hybrid procedures
are rapidly increasing with the collaboration of
cardiologists and cardiovascular surgeons and this
case is a prominent example of the collaboration
with cardiologist and cardiovascular surgeon in a
hybrid procedure.Disclosure
No conflict of interest.Conflict of interest
None.
References
[1] Vedantham S, Picus D, Sanchez AL, Braverman A, Moon
MR, Sundt T, et al. Percutaneous management of ischemic
complications in patients with type-B aortic dissection. J
Vasc Interv Radiol 2003;14:181–93.
[2] DeSanctis RW, Doroghazi RM. Aortic dissection. N Engl J
Med 1987;317:1060–7.
[3] Slater EE, DeSanctis RW. The clinical recognition of
dissecting aortic aneurysm. Am J Med 1976;60:625–33.
[4] Dake MD, Kato N, Mitchell RS, Semba CP, Razavi MK,
Shimono T, et al. Endovascular stent-graft placement for
the treatment of acute aortic dissection. N Engl J Med
1999;340:1546–52.
[5] García-Rinaldi R, Carballido J, Mojica J, Soltero ER, Curcic
S, Barceló J, et al. Surgical treatment of aortic dissections:
initial experience with the adventitial inversion technique.
Ann Thorac Surg 1998;65(5):1255–9.
[6] Belov IuV, Komarov RN, Stepanenko AB, Gens AP, Stogniı˘
NIu. Surgical treatment of the aortic dissection type B:
analysis of 15 years’ experience. Khirurgiia (Mosk)
2011:14–7.
[7] Khoynezhad A, Rao R, Trento A, Gewertz B. Management
of acute type B aortic dissections and acute limb ischemia. J
Cardiovasc Surg (Torino) 2011;52(4):507–17.
[8] Safi HJ, Miller CC, Subramaniam MH, Campbell MP,
Iliopoulos DC, O’Donnell JJ, et al. Thoracic and
Thoracoabdominal aneurysm repair using
cardiopulmonary bypass, profound hypothermia and
circulatory arrest via left side of the chest incision. J Vasc
Surg 1998;28:591–8.
[9] Deeb GM, Williams MD, Bolling FS, Quint LE, Monaghan
H, Sievers J, et al. Surgical delay for acute type A dissection
with malperfusion. Ann Thorac Surg 1997;64:1669–77.
